Matthew Doctor's Securities Transactions and Sale Plan

Matthew Doctor, a former officer and director of Regis Corp, has filed a Form 144 notice indicating the planned sale of 745 common shares acquired through an option granted on 05/05/2022. The sale is scheduled for 10/20/2025, with an aggregate market value of $22,722.50. Additionally, Doctor has reported significant securities sales in the past three months, totaling 12,897 shares with gross proceeds of $375,510.47. These transactions occurred on 09/18/2025, 09/19/2025, 09/26/2025, and 10/15/2025. The filing highlights ongoing changes in Doctor's holdings and financial interests related to Regis Corp.